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ABSTRACT
Objectives: To test the impact of a hospital
pharmacist-prepared interim residential care
medication administration chart (IRCMAC) on
medication administration errors and use of locum
medical services after discharge from hospital to
residential care.
Design: Prospective pre-intervention and post-
intervention study.
Setting: One major acute care hospital and one
subacute aged-care hospital; 128 residential care
facilities (RCF) in Victoria, Australia.
Participants: 428 patients (median age 84 years, IQR
79e88) discharged to a RCF from an inpatient ward
over two 12-week periods.
Intervention: Seven-day IRCMAC auto-populated with
patient and medication data from the hospitals’
pharmacy dispensing software, completed and signed
by a hospital pharmacist and sent with the patient to
the RCF.
Primary and secondary outcome
measures: Primary end points were the
proportion of patients with one or more missed
or signiﬁcantly delayed (>50% of prescribed
dose interval) medication doses, and the proportion
of patients whose RCF medication chart was
written by a locum doctor, in the 24 h after
discharge. Secondary end points included RCF
staff and general practitioners’ opinions about the
IRCMAC.
Results: The number of patients who experienced one
or more missed or delayed doses fell from 37/202
(18.3%) to 6/226 (2.7%) (difference in percentages
15.6%, 95% CI 9.5% to 21.9%, p<0.001). The
number of patients whose RCF medication chart was
written by a locum doctor fell from 66/202 (32.7%) to
25/226 (11.1%) (difference in percentages 21.6%,
95% CI 13.5% to 29.7%, p<0.001). For 189/226
(83.6%) discharges, RCF staff reported that the
IRCMAC improved continuity of care; 31/35 (88.6%)
general practitioners said that the IRCMAC reduced the
urgency for them to attend the RCF and 35/35 (100%)
said that IRCMACs should be provided for all patients
discharged to a RCF.
Conclusions: A hospital pharmacist-prepared
IRCMAC signiﬁcantly reduced medication errors and
ARTICLE SUMMARY
Article focus
- Medication administration errors are common
when patients are discharged from hospital to
a residential care facility (RCF). In Australia,
a contributing factor is the need for the patient’s
primary care doctor to attend the RCF at short
notice to write a medication administration chart;
when the doctor cannot attend, doses may be
missed or delayed and a locum doctor may be
called to write a medication chart.
- The objective of this study was to test the impact
of a hospital pharmacist-prepared residential
care medication administration chart (IRCMAC)
on medication administration errors and use of
locum medical services after discharge from
hospital.
Key messages
- Provision of a hospital pharmacist-prepared
IRCMAC resulted in signiﬁcant reductions in
missed or delayed medication doses and use of
locum medical services after discharge from
hospital.
- RCF staff reported that the IRCMAC improved
continuity of care, and primary care doctors
reported that it reduced pressure on them to
attend RCFs at short notice.
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Open Access Researchuse of locum medical services after discharge from hospital to
residential care.
INTRODUCTION
Continuity of medication management is often
compromised when patients are discharged from
hospitals to residential care facilities (RCF) such as
‘nursing homes’ and ‘care homes’.
1e8 Missed, delayed or
incorrect medication administration is common.
Patients discharged to RCFs have complex and inten-
sive medication needs.
1 An Australian study reported
that patients discharged to RCFs were prescribed an
average of 11 medications of which seven were new or
had been modiﬁed during hospitalisation.
2 The median
time between arrival at the RCF and the ﬁrst scheduled
medication dose was 3 h and ‘when required’ (prn)
medications were sometimes needed sooner.
2
In a study conducted in the USA, most patients
transferred to a RCF had one or more medication doses
missed; on average, 3.4 medications per patient were
omitted or delayed for an average of 12.5 h.
5 In another
US study, medication discrepancies related to transfers
to and from hospitals and RCFs resulted in adverse drug
events in 20% patients.
7 In an analysis of medication
incidents that resulted in patient harm in Canadian
long-term care facilities, patient transfer was identiﬁed as
a common factor.
8
Australian studies report that up to 23% of patients
experience delays or errors in medication administration
after discharge from hospital to a RCF.
2 39A key reason
is difﬁculty accessing primary care doctors (general
practitioners (GPs)) at short notice to write or update
RCF medication charts.
231 0
Delays in obtaining an up-to-date medication chart can
range from a few hours up to several days.
2 10 11 In the
absence of an up-to-date medication chart, RCF staff may
withhold medications, administer them without
a current medication chart or revert to pre-hospital-
isation medication regimens.
21 1The clinical signiﬁ-
cance of delays or errors in medication administration
depends on the clinical status of the patient, the nature
of the medications involved and the length of the delay.
In some cases, no adverse event occurs. However, delays
in access to medications for symptom control (eg, anal-
gesics and medications for terminal care) can adversely
impact on quality of life, and delays or errors with
regularly scheduled medications (eg, anti-epileptics and
antibiotics) may have serious consequences.
11
Unplanned hospital readmissions have been reported as
a result of failure to receive prescribed medications after
transfer to a RCF.
11 When the patient’s GP is unable to
attend, a locum medical service may be called to write
the RCF medication chart; however, this does not elim-
inate missed doses and errors, and it adds signiﬁcantly to
the cost of care.
2
When GPs (or locums) write RCF medication charts,
they often do not have access to accurate discharge
medication information.
2 391 2Medication changes
made in hospital are frequently not explained in medical
discharge summaries, and discrepancies between
discharge summaries and discharge prescriptions occur
in up to 80% of cases.
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Some Australian hospitals have attempted to improve
continuity of medication management by providing 5- or
7-day interim residential care medication administration
charts (IRCMACs) on discharge. These charts enable
medications to be safely administered upon arrival at the
RCF, without the need for urgent GP or locum atten-
dance. They enable the GP to attend the RCF and review
the patient at a clinically appropriate time, a few days
after discharge, rather than on the day of hospital
discharge. Use of IRCMACs is not widespread, and
where they have been used, there has been no evaluation
of their impact on medication administration or use of
locum medical services. Most Australian hospitals do not
use electronic prescribing systems and, based on anec-
dotal experience, expecting hospital doctors to prepare
handwritten interim medication charts at the point of
discharge is not a reliable, safe or sustainable method for
providing IRCMACs. This is because it relies on hospital
doctors remembering to write the chart, it introduces
risk of discrepancies between the IRCMAC and the
discharge prescription(s) and it adds to hospital doctors’
workload.
For this study, a novel method for preparing IRCMACs
was developed. IRCMACs were generated via hospital
pharmacy dispensing software during the processing of
discharge prescriptions, with auto-population of the
chart with patient, prescriber and medication data
(name, strength and directions). This occurred after the
discharge prescription had been reviewed by a pharma-
cist (including reconciliation with pre-admission medi-
cations and inpatient medication charts) and errors
corrected. This method was chosen to avoid the need for
manual transcription, minimise additional workload and
ensure the IRCMAC and discharge medications were
concordant. An additional novel aspect, designed to
address gaps in provision of discharge medication
ARTICLE SUMMARY
Strengths and limitations of this study
- This is the ﬁrst study to evaluate the impact of a hospital-
provided IRCMAC on medication errors or use of locum
medical services. Strengths were that the two study groups
were well matched in terms of demographics, ward type,
number of medications and number of RCFs.
- The main limitations were the use of a pre-intervention and
post-intervention study design and data collection via RCF staff
telephone interview. However, quantitative data on medication
errors and use of locum services were validated by strongly
positive feedback from RCF staff and doctors and widespread
uptake and ongoing use of the IRCMAC.
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each medication (unchanged, new or dose changed,
with date and reason for change if known to the phar-
macist), a list of medications ceased (with the date and
reason, if known) and time of last dose given in hospital
for each medication. These details were manually added
by the pharmacist.
The aim of this study was to evaluate the impact of the
hospital pharmacist-prepared IRCMAC on continuity of
medication administration and use of locum medical
services following discharge to RCFs.
METHODS
A prospective pre-intervention and post-intervention
study was undertaken at a 400-bed acute care hospital
and an 80-bed subacute aged care (geriatric assessment
and rehabilitation) hospital within a major metropolitan
public health service in Melbourne, Australia, over two
12-week periods (January to April and September to
November 2009). A detailed analysis of the baseline
(pre-intervention) data has been previously published
2;
this paper compares post-implementation data with that
baseline data. The study was approved by the Austin
Health and Monash University Human Research Ethics
Committees.
Patients were eligible for inclusion if they were
discharged to a RCF following an overnight stay on an
inpatient ward. Exclusion criteria were discharge under
the Transition Care Programme (a hospital-managed
short-term residential care programme) or returning to
an RCF with no medication changes made in hospital.
During the pre-intervention (control) period, no
IRCMAC was provided. The hospitals’ discharge policy
included provision of at least 7 days supply of all
prescribed medications for patients discharged to a new
RCF or new and changed medications for patients
returning to a RCF, dispensed in original packaging. A
photocopy of the discharge prescription(s) was provided
in the bag of medications.
During the post-intervention period, a 7-day IRCMAC
was prepared by a hospital pharmacist. The IRCMAC
and a photocopy of the discharge prescription(s) were
placed in a transparent red plastic sleeve along with
instructions for using the IRCMAC. The red sleeve was
placed in a clear plastic bag with the discharge medica-
tions and transported with the patient. The pharmacist
telephoned the RCF prior to discharge to notify them
that an IRCMAC would be provided. No other discharge
procedures were changed.
Prior to implementation of the IRCMAC, stakeholders
including hospital and RCF staff, GPs and regulatory,
professional and accreditation organisations were
consulted (appendix 1). They provided input into the
design of the IRCMAC and procedures for its prepara-
tion and use. All pharmacists involved in hospital
discharge management received training in IRCMAC
preparation. A standard operating procedure for use of
the IRCMAC at RCFs was mailed to all RCFs that
accepted patients from the health service during the
pre-intervention study period.
Data collection
Data collection methods have been described in detail
previously.
2 Brieﬂy, a structured telephone interview was
conducted with a RCF staff member responsible for
managing the patient’s medications using a pre-piloted
questionnaire. Interviews were conducted approximately
24 h after discharge. In the post-intervention period, for
logistical reasons, interviews were not conducted on
weekends; therefore, interviews for Friday and Saturday
discharges occurred 48e72 h after discharge. Data
collected included time of arrival at the RCF, whether
the RCF medication chart had been written/updated in
time for the ﬁrst dose of regularly scheduled medication,
who wrote/updated the chart (if written) and whether
any doses had been missed or delayed since the resident
arrived (and if so, the medication name and length of
delay). In the post-intervention period, additional
questions were asked, including whether an IRCMAC
was received, whether it was used to record medication
administration and whether the RCF staff member felt
that the IRCMAC improved the medication transfer
process. Also in the post-intervention period, a second
structured telephone interview was performed on day 8
post-discharge if the patient had not had their RCF
medication chart written/updated at the time of the
initial interview (to determine who wrote/updated the
RCF medication chart and whether the IRCMAC avoided
or merely delayed locum doctor attendance).
To assess GP satisfaction with the IRCMAC, a four-item
questionnaire was mailed to the GPs of patients who had
been provided with an IRCMAC during the last 4 weeks
of the post-intervention period, along with a pre-
addressed reply-paid envelope. There was no follow-up
of non-responders.
Primary end points were the proportion of patients
who experienced one or more missed or signiﬁcantly
delayed medication doses, and the proportion of
patients whose RCF medication chart was written/
updated by a locum doctor, in the 24 h after discharge.
Missed or signiﬁcantly delayed doses were deﬁned as
regularly scheduled medication dose completely
omitted, regularly scheduled medication dose delayed by
more than 50% of the prescribed dose interval or ‘when
required’ (prn) medication delayed by any length of
time if it was required by the patient.
Secondary end points were the proportion of patients
for whom a ‘workaround’ was used by RCF staff to avoid
a delayed or missed dose when an updated medication
chart was not available and RCF staff and GP satisfaction.
A ‘workaround’ was deﬁned as any action taken by RCF
staff that was not usual practice for medication admin-
istration at the RCF (eg, using a copy of a hospital
inpatient medication chart or administering medications
without a medication chart).
The minimum sample size required was 112 patients
per group, based on a predicted reduction in the
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(power 80%, level of signiﬁcance 0.05, two sided).
Statistical analysis was performed using SPSS V.19.0 (IBM
SPSS Statistics). The c
2 test was used to compare cate-
gorical data and ManneWhitney U test for all other
(non-parametric) data.
RESULTS
Of 593 patients discharged to a RCF, 428 met the
inclusion criteria and had a post-discharge RCF staff
interview completed (ﬁgure 1).
There were no signiﬁcant differences between the pre-
intervention and post-intervention groups in terms of
age, gender, length of hospital stay, number of medica-
tions, level of residential care or time from discharge to
ﬁrst scheduled dose (table 1). The distribution of
patients across RCFs was similar in the two study periods,
with a median of two patients discharged to each RCF in
both periods (ﬁgure 1).
In the pre-intervention period, 75 medications for 37
(18.3%) patients had one or more doses missed or
signiﬁcantly delayed within 24 h of discharge from
hospital. Following implementation of the IRCMAC,
nine medications for six (2.7%) patients were missed or
delayed (difference in percentages 15.6%, 95% CI 9.5%
to 21.9%, p<0.001). Missed doses accounted for most
medication administration errors: 70 (93%) pre-inter-
vention and 9 (100%) post-intervention.
The number of RCF medication charts written or
updated by a locum medical service within 24 h of
discharge declined following implementation of the
IRCMAC, from 66 (32.7%) to 25 (11.1%) (difference in
percentages 21.6%, 95% CI 13.5% to 29.7%, p<0.001).
Day 8 telephone interviews identiﬁed only one addi-
tional patient whose RCF medication chart was subse-
quently written/updated by a locum medical service.
One hundred and seventy-ﬁve (77.4%) patients in the
post-intervention period did not have their RCF long-
term medication chart written/updated by a GP or
locum service in time for their ﬁrst scheduled medica-
tion dose. In 147 (84%) of these cases, the RCF received
and used the IRCMAC, 20 (11%) received but did not
use the IRCMAC and eight (5%) did not receive the
IRCMAC. The number of patients for whom a ‘work-
around’ was used to avoid a missed or delayed dose fell
following implementation of the IRCMAC, from 90
(44.6%) to 22 (9.7%) (p<0.001).
For 189 (83.6%) discharges, the interviewed RCF staff
member reported that the IRCMAC improved continuity
of medication management, and in 139 (61.5%) cases,
the information about medication changes was useful.
Questionnaires were sent to 84 GPs. Four were returned
as the GP was no longer managing the resident’s care
and 35 were completed (response rate 43.8%). Thirty-
one (88.6%) GPs reported that provision of an IRCMAC
reduced urgency to attend the RCF after patients were
Figure 1 Patient ﬂow diagram.
*Discharged to 90 RCFs (median
two patient transfers per RCF,
IQR 1e3, range 1e9);^ discharged
to 84 RCFs (median two patient
transfers per RCF, IQR 1e3,
range 1e14).
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comfortable with a hospital-provided IRCMAC being
used at the RCF for up to 7 days until they reviewed the
patient, 34 (97.1%) reported that ‘Change status’ and
‘Medications ceased’ sections on the IRCMAC were
helpful, and 35 (100%) agreed that provision of an
IRCMAC should be standard practice for all patients
discharged from hospital to a RCF. Examples of
comments from RCF staff and GPs are provided in
table 2, categorised by theme.
DISCUSSION
This is the ﬁrst study to evaluate a hospital-provided
IRCMAC for patients discharged to residential care. It
demonstrated that a 7-day IRCMAC prepared by hospital
pharmacists (linked with review and processing of
Table 1 Patient demographics
Pre-intervention (n[202) Post-intervention (n[226) p Value
Age (years) (median (IQR)) 84 (79e88) 84 (79e88) 0.73
Gender (n (%) female) 119 (58.9) 142 (62.8) 0.43
Length of stay in hospital (days) (median (IQR)) 11.5 (6.0e33) 11.0 (5.8e33) 0.63
Number of medications prescribed on discharge from hospital (median (IQR))
Regular 9.0 (6.5e12) 9.0 (7.0e12) 0.41
When required (prn) 1.0 (0e2.0) 1.0 (0e2.0) 0.15
Total 11.0 (7.0e13.5) 10.0 (8.0e14) 0.60
New admission to RCF (n (%)) 76 (37.6) 79 (35.0) 0.62
Level of care at RCF (n (%))
High* 97 (48.0) 126 (55.7) 0.21
Lowy 92 (45.5) 89 (39.4)
Otherz 13 (6.4) 11 (4.9)
Time between arrival at RCF and ﬁrst scheduled
dose due (median (IQR), minutes)
180 (60e360) 180 (60e330) 0.17
*Australian Government-approved and subsidised residential aged care place for a person who needs a high level of assistance with activities of
daily living and 24-h nursing care.
yAustralian Government-approved and subsidised residential aged care place for a person who needs a lower level of personal and nursing
care.
zRCF providing non-government subsidised personal and/or nursing care (eg, Supported Residential Service).
RCF, residential care facility.
Table 2 Examples of comments from residential care staff and general practitioners about the IRCMAC
Theme Comments
Reduction in need for urgent
medical practitioner attendance
“Avoided us needing to call locum” [Nurse]
“Beautiful, perfect, gives time to organise doctor” [Nurse]
“So good. Saves getting locum, saves getting a phone order” [Nurse]
“Very good, can’t get doctor always. Could accept patients
(from hospital) later now. Normally only before 1 pm”
[Nurse Manager]
“This is a great help in arranging an easy move from hospital to
residential care facility and helps take the pressure off the ﬁrst
few daysdthank you” [GP]
Clarity of information “Brilliant, able to read, very easy to read” [Nurse]
“The typed nature of these charts helps a lot e some hand
written discharge medication lists in the past have been
illegible” [GP]
Usefulness of information “Change status alerted nurse of new medications” [Nurse]
“Did not need to check when last dose was given” [Nurse]
Reduction in medication
administration errors
“Wouldn’t have been able to administer medications (without it)” [Nurse]
“ . Usually cannot administer from script so this allowed for signing” [Nurse]
Lack of familiarity with IRCMAC
(RCF staff who received but
did not use the IRCMAC)
“ . didn’t realise it could be used til the day after” [Nurse]
“Unfamiliar with the chart though fantastic idea” [Nurse]
“Would have been helpful if staff familiar” [Nurse]
Other “Interim chart is very useful. Would be useful if done for every
patient discharged to residential facilities on a regular basis” [GP]
“(I) think this is the best idea ever” [GP]
GP, general practitioner; IRCMAC, Interim Residential Care Medication Administration Chart; RCF, residential care facility.
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cation administration, reduced pressure on the GP
workforce and reduced the need for locum medical
services to write RCF medication charts. It also led to
a reduction in potentially unsafe medication adminis-
tration ‘workarounds’ used by RCF staff.
Clinical outcomes were not assessed, but case reports
and anecdotal evidence indicate that ‘workarounds’
and missed doses sometimes result in adverse
outcomes.
7 81 11 6Of the 75 missed and delayed medi-
cations in the pre-intervention period, a moderate or
high risk of adverse outcome was considered by a multi-
disciplinary expert panel to be likely in 49 (65.3%)
cases.
2
Reduced reliance on locum doctors to write medica-
tion charts after hospital discharge also has potential to
improve patient safety because the locum would be
unfamiliar with the patient and may not be the most
appropriate person to write the long-term care medica-
tion chart (which may be used for up to 6 months). The
IRCMAC enabled GPs to review their patients (and write
long-term care medication charts) at a clinically appro-
priate time, a few days after discharge, rather than on the
day of hospital discharge (when the patient should not
require a clinical review).
The duration of the IRCMAC was limited to 7 days to
ensure that post-discharge medical review could not be
excessively delayed, while also providing ﬂexibility for
GPs in the scheduling of their visit to the RCF (during
stakeholder consultation, some GPs reported that they
usually attend the RCF for routine patient care activities
on a set day each week). If the patient is stable and the
GP’s usual day of attendance is 7 days away, a 7-day chart
avoids the need for the GP to make an extra visit and/or
the need for locum attendance. If the patient is clinically
unstable, the GP can attend sooner.
We did not assess whether there was a change in the
time from hospital discharge to ﬁrst GP visit. Anecdotally
we noted that the chart was usually used for <7 days.
While there is a potential risk that the IRMCAC may
delay GP review of an unstable patient, the risk may be
smaller with the IRCMAC than without the IRCMAC.
This is because without the IRCMAC, a locum medical
service is often called to write a long-term care medica-
tion chart on the day of discharge,
2 and this chart will
last for up to 6 months; therefore, the patient’s GP can
delay their attendance for much longer than 7 days.
Another beneﬁt of reducing reliance on locum
medical services is that it reduces healthcare costs. If the
results of this study were replicated across all hospitals in
Australia (based on 2001e2002 discharge data
17 and the
minimum Medicare Australia locum medical consulta-
tion rebate in 2010 ($A126)), savings to the Australian
Government in excess of $A2.1 million annually could
be realised. Avoidance of adverse medication events may
lead to further cost savings. The IRCMAC could also lead
to efﬁciency gains within the RCF and GP workforce;
telephone interviews and satisfaction surveys suggested
that the IRCMAC resulted in considerable (though
unquantiﬁed) time savings for RCF staff and GPs.
Countering these savings would be costs incurred by
hospitals to deliver the IRCMAC, but in our experience,
these are signiﬁcantly less than the likely savings
(approximately 10 Australian dollars per IRCMAC for
labour and consumables, excluding software and set-up
costs, in a setting in which pharmacists were already
conducting admission and discharge medication recon-
ciliation and entering discharge medication data into
dispensing software; greater labour costs for IRCMAC
provision would be incurred if these tasks needed to be
introduced).
Although RCF medication charts are traditionally
written by medical practitioners, the IRCMAC used in
this study was able to be legally prepared and signed by
the pharmacist because in the RCF setting, the chart was
an administration record, not a prescription, and
therefore did not need the signature of a medical prac-
titioner. Preparing the IRCMAC in this way provided
a number of advantages. It ensured that IRCMAC
production occurred after the discharge prescription
had been reviewed and reconciled by a pharmacist and
errors corrected, and it enabled auto-population of the
chart from the pharmacy dispensing software. This
ensured a high level of concordance between the
IRCMAC and the discharge prescription. An audit of
a random selection of 76 IRCMACs prepared during
this study revealed a medication discrepancy rate of
9/870 (1.0%).
18 Although there are no studies that have
assessed accuracy of handwritten IRCMACs, medication
transcription error rates on handwritten inpatient
orders and discharge summaries range from 12% to
56%.
14 19e21
For 11% of patients, the RCF received an IRCMAC but
did not use it. In some cases, this was because a doctor
attended in time to write a new RCF medication chart. In
other cases, it was because the RCF had a policy
requiring all admissions to be reviewed/admitted by
a medical practitioner or stating that all medication
administration charts must be written by a medical
practitioner. Sometimes RCF staff did not use the chart
because they were unfamiliar with it (table 2).
In our study, the hospital supplied medications on
discharge along with the IRCMAC. In settings in which
the hospital does not supply discharge medications, the
IRCMAC may be less effective but would still be expected
to provide some beneﬁts. It may reduce pressure on the
GP workforce and use of locum medical services. And
because the IRCMAC provides RCF staff with clarity as to
what the intended discharge regimen is, if pre-admission
medications are available at the RCF, with an IRCMAC,
they can be given correctly, without delay. For new or
changed medications, whether the IRCMAC would be
effective will depend on how the medications are
supplieddif delays in medication supply and/or delivery
occur then missed doses may still occur until the medi-
cations become available, but if the medications are
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IRCMAC could facilitate timely and accurate administra-
tion.
There were some limitations with our study method-
ology. Data on missed and delayed doses were obtained
by telephone interview, introducing risk of under-
reporting and recall bias. However, as described else-
where,
2 we piloted several methods of data collection,
and telephone interview 24 h after discharge was judged
to be the most reliable and practical. Any under-
reporting and recall bias is likely to have been similar
during the pre-intervention and post-intervention
periods. While transfer-related medication administra-
tion errors may continue for several days after
discharge,
49our methodology did not enable us to
assess what proportion of errors persisted beyond 24 h
after discharge. Use of a pre-intervention and post-
intervention study design meant that the interviewer
could not be blinded to group allocation and that factors
other than the IRCMAC could have contributed to the
reduction in medication administration errors and
locum medical service attendances over time. However,
the strongly positive feedback from GPs and RCF staff
regarding the impact of the IRCMAC suggests that it was
the primary cause of observed improvements and
because the problems addressed by the IRCMAC have
been long standing, it is unlikely that over the space of
a few months, they would decline signiﬁcantly without
speciﬁc intervention. Furthermore, the participating
hospitals have continued to provide IRCMACs since this
study ﬁnished and (unsolicited) positive feedback
continues to be received. Several RCFs have indicated
that they are now happy to accept patients on weekends
or after hours, provided they receive the IRCMAC,
whereas previously they would not. A major locum
medication service in the area has indicated that since
the IRCMAC was introduced, they infrequently receive
calls to write medication charts following hospital
discharge. Data were collected from RCFs within
approximately 24 h for all discharges in the pre-inter-
vention period, but up to 48e72 h in the post-interven-
tion period for Friday and Saturday discharges (24 h for
all others). It is possible that the longer time between
discharge and interview in the post-intervention period
may have increased the risk of recall bias. However,
Saturday discharges were rare (5/226), and it was our
experience that delaying interviews for Friday discharges
until Monday was advantageous because the interview
was more likely to involve a RCF staff member who was
present on Friday, when the patient arrived. Therefore,
this minor difference in methodology was unlikely to
have resulted in underestimation of error prevalence.
In conclusion, implementation of a hospital pharma-
cist-prepared IRCMAC led to signiﬁcant improvements
in continuity of medication administration and reduced
reliance on locum medical services to write medication
charts after discharge from hospital to RCFs. As a result
of this study, hospital pharmacist-prepared IRCMACs
have been implemented in several Australian hospitals,
and a national IRCMAC and guidelines addressing
continuity of medication management on transfer from
hospital to RCF are planned. Although health systems
vary between countries, problems with continuity of
medication management on discharge from hospital to
residential care have been reported internationally,
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so the ﬁndings of this study may be widely applicable.
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APPENDIX 1
Stakeholders consulted during development of the IRCMAC
Australian government and professional bodies:
< Aged Care Standards & Accreditation Agency
< Australian Nursing Federation
< North East Valley Division of General Practice
< Northern Division of General Practice
< Nurses Board of Victoria
< Pharmacy Board of Australia
< Victorian Department of HealthdAged Care Branch
< Victorian Department of HealthdAmbulatory & Continuing Care
Programs Branch
< Victorian Department of HealthdDrugs and Poisons Unit
< Victorian Department of HealthdQuality Use of Medicines
Programme
Individual health professionals and aged care staff:
< Community pharmacists (n¼4)
< Hospital pharmacists (n¼6)
< Hospital doctors (n¼3)
< Hospital aged care liaison nurse (n¼1)
< RCF staff (directors of nursing, care coordinators, division 1 & 2
registered nurses, personal care assistants) (n¼34)
< GPs (n¼6)
PAGE fraction trail=7.5
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